KALA BIO, Inc.
KALA
$2.93
-$0.16-5.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.98M | -35.84M | -37.23M | -35.65M | -38.51M |
| Total Depreciation and Amortization | 317.00K | 332.00K | 267.00K | 261.00K | 259.00K |
| Total Amortization of Deferred Charges | -667.00K | 774.00K | 980.00K | 1.12M | 1.25M |
| Total Other Non-Cash Items | 860.00K | 5.81M | 9.64M | 9.19M | 9.40M |
| Change in Net Operating Assets | -5.52M | -3.11M | 457.00K | -2.29M | -1.78M |
| Cash from Operations | -31.99M | -32.03M | -25.88M | -27.36M | -29.38M |
| Capital Expenditure | -15.00K | -84.00K | -175.00K | -195.00K | -208.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -15.00K | -84.00K | -175.00K | -195.00K | -208.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -22.51M | -7.62M | -7.60M | -5.07M | -5.05M |
| Issuance of Common Stock | 9.21M | 11.75M | 11.69M | 26.66M | 26.66M |
| Repurchase of Common Stock | -- | -- | -162.00K | -162.00K | -162.00K |
| Issuance of Preferred Stock | 1.80M | 0.00 | 0.00 | 0.00 | 8.54M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -120.00K | -120.00K | -120.00K | -120.00K | -119.00K |
| Cash from Financing | -11.62M | 4.01M | 3.80M | 21.30M | 29.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.62M | -28.11M | -22.26M | -6.26M | 286.00K |